U.S. life sciences companies secured $1.9 billion in venture capital funding in the fourth quarter of 2009, led by the $55 million second-round haul of Durham, NC, medical device company TransEnterix, according to a report by online venture capital database VentureDeal.The $1.9 billion represented almost no change compared to the third quarter and continued a stable trend of funding for companies in the biotechnology, pharmaceutical and medical-devices fields.
Biotechnology received the most money, $871 million among 69 companies. Medical devices followed with 78 companies raising $572 million in the quarter. 45 pharmaceutical companies raised $460 million.
No comments:
Post a Comment